Symptom remission

Assessment | Biopsychology | Comparative | Cognitive | Developmental | Language | Individual differences | Personality | Philosophy | Social |
Methods | Statistics | Clinical | Educational | Industrial | Professional items | World psychology |

Clinical: Approaches · Group therapy · Techniques · Types of problem · Areas of specialism · Taxonomies · Therapeutic issues · Modes of delivery · Model translation project · Personal experiences ·

---

Symptom remission is the improvement in psychiatric symptoms but in th econtext of their later return.

---

See also

• Spontaneous remission
• Remission (disorders)

Key texts

Papers

• Abramowitz, J. S. (1996). Variants of exposure and response prevention in the treatment of obsessive-compulsive disorder: A meta-analysis: Behavior Therapy Vol 27(4) Fal 1996, 583-600.
• Alexopoulos, G. S., Murphy, C. F., Gunning-Dixon, F. M., Latoussakis, V., Kanellopoulos, D., Klimstra, S., et al. (2008). Microstructural white matter abnormalities and remission of geriatric depression: American Journal of Psychiatry Vol 165(2) Feb 2008, 238-244.
• Altamura, A. C., Santini, A., & Mundo, E. (2006). Treatment issues in bipolar II depression: International Journal of Neuropsychopharmacology Vol 9(6) Dec 2006, 775-776.
• Anagnostopoulos, M. G. (1975). The effect of patient expectancies and non-specific professional attention on symptom reduction without psychotherapy: Dissertation Abstracts International.
• Arya, D. K. (1997). Resolution of episode of major depressive disorder with emergence of Ganser syndrome symptoms: Irish Journal of Psychological Medicine Vol 14(1) Mar 1997, 35-37.
• Ballenger, J. C. (1999). Clinical guidelines for establishing remission in patients with depression and anxiety: Journal of Clinical Psychiatry Vol 60(Suppl 22) 1999, 29-34.
• Ballenger, J. C. (2001). Overview of different pharmacotherapies for attaining remission in generalized anxiety disorder: Journal of Clinical Psychiatry Vol 62(Suppl19) 2001, 11-19.
• Bandelow, B. (2006). Defining Response and Remission in Anxiety Disorders: Toward an Integrated Approach: CNS Spectrums Vol 11(10,Suppl12) Oct 2006, 21-28.
• Barbarotto, R., Castignoli, G., Pasettti, C., & Laiacona, M. (2001). Global cognitive decline in schizophrenia with remission of symptoms? : Brain and Cognition Vol 46(1-2) Jun-Jul 2001, 29-34.
• Bebelaar, J. (1978). The process and outcome of stress psychotherapy: A case study: Dissertation Abstracts International.
• Benjamin, A. B. (2007). Medication management with panic disorder in the exercise state: Some prescribing guidelines: CNS Spectrums Vol 12(3) Mar 2007, 184.
• Bergemann, N., Abu-Tair, F., & Strowitzki, T. (2007). Estrogen in the treatment of late-onset schizophrenia: Journal of Clinical Psychopharmacology Vol 27(6) Dec 2007, 718-720.
• Bhandari, S. (1995). Neuropsychological function in manic-depressive psychosis: British Journal of Psychiatry Vol 167(6) Dec 1995, 824-825.
• Biederman, J., Mick, E., Faraone, S. V., & Burback, M. (2001). Patterns of remission and symptom decline in conduct disorder: A four-year prospective study of an ADHD sample: Journal of the American Academy of Child & Adolescent Psychiatry Vol 40(3) Mar 2001, 290-298.
• Biringer, E., Mykletun, A., Sundet, K., Kroken, R., Stordal, K. I., & Lund, A. (2007). A longitudinal analysis of neurocognitive function in unipolar depression: Journal of Clinical and Experimental Neuropsychology Vol 29(8) Nov 2007, 879-891.
• Bleich, S., Degner, D., Kropp, S., Hajak, G., & Ruther, E. (2000). Risperidone in disorganised schizophrenia: Australian and New Zealand Journal of Psychiatry Vol 34(3) Jun 2000, 534-535.
• Blomstedt, P., Hariz, G.-M., & Hariz, M. I. (2006). Pallidotomy versus pallidal stimulation: Parkinsonism & Related Disorders Vol 12(5) Jun 2006, 296-301.
• Bobholz, J. A., Rao, S. M., Lobeck, L., Elsinger, C., Gleason, A., Kanz, J., et al. (2006). fMRI study of episodic memory in relapsing-remitting MS: Correlation with T2 lesion volume: Neurology Vol 67(9) Nov 2006, 1640-1645.
• Brumby, A., & Steinhausen, H.-C. (1989). The course of enuresis in childhood and adolescence: Praxis der Kinderpsychologie und Kinderpsychiatrie Vol 38(1) Jan 1989, 2-5.
• Buckley, P. F., Harvey, P. D., Bowie, C. R., & Loebel, A. (2007). The relationship between symptomatic remission and neuropsychological improvement in schizophrenia patients switched to treatment with ziprasidone: Schizophrenia Research Vol 94(1-3) Aug 2007, 99-106.
• Bufka, L. F. (2000). Depression-focused treatment in the context of PTSD and other comorbid disorders: Cognitive and Behavioral Practice Vol 7(1) Win 2000, 126-130.
• Bulloch, A. G., & Patten, S. B. (2008). Non-remission of depression in the general population as assessed by the HAMD-7 Scale: Depression and Anxiety Vol 25(5) 2008, 393-397.
• Burns, D. D., & Spangler, D. L. (2000). Does psychotherapy homework lead to improvements in depression in cognitive-behavioral therapy or does improvement lead to increased homework compliance? : Journal of Consulting and Clinical Psychology Vol 68(1) Feb 2000, 46-56.
• Burns, D. D., & Spangler, D. L. (2001). Can we confirm our theories? Can we measure causal effects?: Reply to Kazantzis et al (2001): Journal of Consulting and Clinical Psychology Vol 69(6) Dec 2001, 1084-1086.
• Burt, V. K. (2004). Plotting the course to remission: The search for better outcomes in the treatment of depression: Journal of Clinical Psychiatry Vol 65(Suppl12) 2004, 20-25.
• Cassidy, F., Murry, E., & Carroll, B. J. (1998). Tryptophan depletion in recently manic patients treated with lithium: Biological Psychiatry Vol 43(3) Feb 1998, 230-232.
• Casten, R. J., Rovner, B. W., Pasternak, R. E., & Pelchat, R. (2000). A comparison of self-reported function assessed before and after depression treatment among depressed geriatric patients: International Journal of Geriatric Psychiatry Vol 15(9) Sep 2000, 813-818.
• Clark, C. P., Frank, L. R., & Brown, G. G. (2001). Sleep deprivation, EEG, and functional MRI in depression: Preliminary results: Neuropsychopharmacology Vol 25(Suppl5) Nov 2001, S79-S84.
• Clausen, L. (2004). Time Course of Symptom Remission in Eating Disorders: International Journal of Eating Disorders Vol 36(3) Nov 2004, 296-306.
• Cohen, R. O. (1977). The effects of four subliminally-introduced merging stimuli on the psychopathology of schizophrenic women: Dissertation Abstracts International.
• Constant, E. L., Borras, L., & Seghers, A. (2006). Aripiprazole is effective in the treatment of Tourette's disorder: International Journal of Neuropsychopharmacology Vol 9(6) Dec 2006, 773-774.
• Correll, C. U., Malhotra, A. K., Kaushik, S., McMeniman, M., & Kane, J. M. (2003). Early Prediction of Antipsychotic Response in Schizophrenia: American Journal of Psychiatry Vol 160(11) Nov 2003, 2063-2065.
• Correll, C. U., Malhotra, A. K., Kaushik, S., McMeniman, M., & Kane, J. M. (2005). "Early Prediction of Antipsychotic Response in Schizophrenia": Correction: American Journal of Psychiatry Vol 162(9) Sep 2005, 1774.
• Coryell, W., Endicott, J., Maser, J. D., Mueller, T., & et al. (1995). The likelihood of recurrence in bipolar affective disorder: The importance of episode recency: Journal of Affective Disorders Vol 33(3) Mar 1995, 201-206.
• Cuffel, B. J., Azocar, F., Tomlin, M., Greenfield, S. F., Busch, A. B., & Croghan, T. W. (2003). Remission, residual symptoms, and nonresponse in the usual treatment of major depression in managed clinical practice: Journal of Clinical Psychiatry Vol 64(4) Apr 2003, 397-402.
• Dalgleish, T., Spinks, H., Yiend, J., & Kuyken, W. (2001). Autobiographical memory style in seasonal affective disorder and its relationship to future symptom remission: Journal of Abnormal Psychology Vol 110(2) May 2001, 335-340.
• Daly, O. E. (2000). The use of stimulants in the treatment of post traumatic stress disorder: Case report: Human Psychopharmacology: Clinical and Experimental Vol 15(4) Jun 2000, 295-300.
• Danilenko, K. V., & Putilov, A. A. (1996). The importance of full summer remission as a criterion for the diagnosis of seasonal affective disorder: Psychopathology Vol 29(4) Jul-Aug 1996, 230-235.
• Daskalopoulos, N. T., & et al. (1976). Progressive disappearance of the psychotropic effect of T.R.H.: Clinical and neuro-endocrinological study: Annales Medico-Psychologiques Vol 2(2) Jul 1976, 279-285.
• De Hert, M., van Winkel, R., Wampers, M., Kane, J., van Os, J., & Peuskens, J. (2007). Remission criteria for schizophrenia: Evaluation in a large naturalistic cohort: Schizophrenia Research Vol 92(1-3) May 2007, 68-73.
• De Leon, O. A., & Furmaga, K. M. (1999). Effects of lamotrigine treatment in epileptic psychosis: Journal of Clinical Psychopharmacology Vol 19(2) Apr 1999, 186-188.
• den Boer, J. A. (1998). Pharmacotherapy of panic disorder: Differential efficacy from a clinical viewpoint: Journal of Clinical Psychiatry Vol 59(8) Aug 1998, 30-36.
• Dollfus, S., & Petit, M. (1995). Negative symptoms in schizophrenia: Their evolution during an acute phase: Schizophrenia Research Vol 17(2) Oct 1995, 187-194.
• Domon, S. E., & Andersen, M. S. (2000). Nefazodone for PTSD: Journal of the American Academy of Child & Adolescent Psychiatry Vol 39(8) Aug 2000, 942-943.
• Edmonds, P. M., Stuttaford, J. M., Penny, J., Lynch, A. M., & Chamberlain, J. (1998). Do hospital palliative care teams improve symptom control? Use of a modified STAS as an evaluation tool: Palliative Medicine Vol 12(5) Sep 1998, 345-351.
• Einarson, T. R. (2004). Errata: Evidence based review of escitalopram in treating major depressive disorder in primary care: International Clinical Psychopharmacology Vol 19(6) Nov 2004, 363.
• Einarson, T. R. (2004). Evidence based review of escitalopram in treating major depressive disorder in primary care: International Clinical Psychopharmacology Vol 19(5) Sep 2004, 305-310.
• Ellershaw, J. E., Smith, C., Overill, S., Walker, S. E., & Aldridge, J. (2001). Care of the dying: Setting standards for symptom control in the last 48 hours of life: Journal of Pain and Symptom Management Vol 21(1) Jan 2001, 12-17.
• Emsley, R., Oosthuizen, P. P., Kidd, M., Koen, L., Niehaus, D. J. H., & Turner, H. J. (2006). Remission in first-episode psychosis: Predictor variables and symptom improvement patterns: Journal of Clinical Psychiatry Vol 67(11) Nov 2006, 1707-1712.
• Ernst, K., & Ernst, C. (1972). Follow-up studies of childhood neuroses: Acta Paedopsychiatrica: International Journal of Child & Adolescent Psychiatry Vol 38(10-12) 1972, 316-324.
• Ettinger, A. B., Devinsky, O., Weisbrot, D. M., Goyal, A., & Shashikumar, S. (1999). Headaches and other pain symptoms among patients with psychogenic non-epileptic seizures: Seizure Vol 8(7) Oct 1999, 424-426.
• Evans, K., Tyrer, P., Catalan, J., Schmidt, U., Davidson, K., Dent, J., et al. (1999). Manual-assisted cognitive-behaviour therapy (MACT): A randomized controlled trial of a brief intervention with bibliotherapy in the treatment of recurrent deliberate self-harm: Psychological Medicine Vol 29(1) Jan 1999, 19-25.
• Fava, G. A., Rafanelli, C., Ottolini, F., Ruini, C., Cazzaro, M., & Grandi, S. (2001). Psychological well-being and residual symptoms in remitted patients with panic disorder and agoraphobia: Journal of Affective Disorders Vol 65(2) Jul 2001, 185-190.
• Feinstein, A., Ron, M. A., & Wessely, S. (1990). Disappearing brain lesions, psychosis and epilepsy: A report of two cases: Journal of Neurology, Neurosurgery & Psychiatry Vol 53(3) Mar 1990, 244-246.
• Fernandez, I. (2007). EMDR as treatment of post-traumatic reactions: A field study on child victims of an earthquake: Educational and Child Psychology Vol 24(1) 2007, 65-72.
• Fernandez, I. (2008). EMDR after a critical incident: Treatment of a tsunami survivor with acute posttraumatic stress disorder: Journal of EMDR Practice and Research Vol 2(2) 2008, 156-159.
• Fitzgerald, P. B., Huntsman, S., Gunewardene, R., Kulkarni, J., & Daskalakis, Z. J. (2006). A randomized trial of low-frequency right-prefrontal-cortex transcranial magnetic stimulation as augmentation in treatment-resistant major depression: International Journal of Neuropsychopharmacology Vol 9(6) Dec 2006, 655-666.
• Fontenelle, L., Soares, I. D., Marques, C., Range, B., Medlowicz, M. V., & Versiani, M. (2000). Sudden remission of obsessive-compulsive disorder by involuntary, massive exposure: The Canadian Journal of Psychiatry / La Revue canadienne de psychiatrie Vol 45(7) Sep 2000, 666-667.
• Frank, E., & et al. (1981). A comparison of nonpatient and bipolar patient-well spouse couples: American Journal of Psychiatry Vol 138(6) Jun 1981, 764-768.
• Frumkin, L. R., Ward, N. G., & Grim, P. S. (1981). A possible cerebral mechanism for the clearing of psychogenic symptoms with amobarbital: Biological Psychiatry Vol 16(7) Jul 1981, 687-691.
• Furusho, J. i., Matsuzaki, K., Ichihashi, I., Satoh, H., Yamaguchi, K., & Kumagai, K. (2001). Alleviation of sleep disturbance and repetitive behavior by a selective serotonin re-uptake inhibitor in a boy with Asperger's syndrome: Brain & Development Vol 23(2) Mar 2001, 135-137.
• Gay, M.-C. (2007). Effectiveness of Hypnosis in Reducing Mild Essential Hypertension: A One-Year Follow-Up: International Journal of Clinical and Experimental Hypnosis Vol 55(1) Jan 2007, 67-83.
• Geiser, F., Imbierowicz, K., Conrad, R., Schilling, G., & Liedtke, R. (2001). Differences between patients classified as "recovered" or "improved" and "unchanged" or "deteriorated" in psychotherapy outcome study: Zeitschrift fur Psychosomatische Medizin und Psychotherapie Vol 47(3) 2001, 250-261.
• Genthner, R. W. (1973). Differences between Black and White patients in the effects of short term hospitalization: Dissertation Abstracts International.
• Goldberg, J. F., Garno, J. L., Leon, A. C., Kocsis, J. H., & Portera, L. (1999). A history of substance abuse complicates remission from acute mania in bipolar disorder: Journal of Clinical Psychiatry Vol 60(11) Nov 1999, 733-740.
• Goldsmith, T. D., & Keck, P. E., Jr. (2000). "Possible interaction of tramadol and antidepressants": Reply: American Journal of Psychiatry Vol 157(5) May 2000, 839.
• Goldsmith, T. D., Shapira, N. A., & Keck, P. E., Jr. (1999). Rapid remission of OCD with tramadol hydrochloride: American Journal of Psychiatry Vol 156(4) Apr 1999, 660-661.
• Gonzalez, C. T. P., & Castro, W. P. (2003). Chronic agoraphobic disorder with 15 years of evolution: Countertherapeutic influence of inadaptative tranquilizer strategies and the process of normalizing vital areas: Analisis y Modificacion de Conducta Vol 29(123) 2003, 102-152.
• Gopal, S., Steffens, D. C., Kramer, M. L., & Olsen, M. K. (2005). Symptomatic Remission in Patients With Bipolar Mania: Results From a Double-Blind, Placebo-Controlled Trial of Risperidone Monotherapy: Journal of Clinical Psychiatry Vol 66(8) Aug 2005, 1016-1020.
• Gossop, M., Marsden, J., & Stewart, D. (2006). Remission of Psychiatric Symptoms Among Drug Misusers After Drug Dependence Treatment: Journal of Nervous and Mental Disease Vol 194(11) Nov 2006, 826-832.
• Green, T. D., Reynolds, C. F., III, Mulsant, B. H., Pollock, B. G., Miller, M. D., Houck, P. R., et al. (1999). Accelerating antidepressant response in geriatric depression: A post hoc comparison of combined sleep deprivation and paroxetine versus monotherapy with paroxetine, nortriptyline, or placebo: Journal of Geriatric Psychiatry and Neurology Vol 12(2) Sum 1999, 67-71.
• Hafeiz, H. B. (1980). Hysterical conversion: A prognostic study: British Journal of Psychiatry Vol 136 Jun 1980, 548-551.
• Heiligman, R., & Paulson, M. J. (1976). The Stiff Man Syndrome: A psychiatric disease? : International Journal of Psychiatry in Medicine Vol 7(4) 1976-1977, 363-371.
• Helldin, L., Kane, J. M., Karilampi, U., Norlander, T., & Archer, T. (2006). Remission and cognitive ability in a cohort of patients with schizophrenia: Journal of Psychiatric Research Vol 40(8) Dec 2006, 738-745.
• Hidalgo, R. (1999). Time-limited psychotherapy: Hidden effects: International Journal of Communicative Psychoanalysis & Psychotherapy Vol 14(1-2) 1999, 9-16.
• Hierholzer, R. (2006). Remission Rates for Depression in STAR*D Study: American Journal of Psychiatry Vol 163(7) Jul 2006, 1293.
• Ho, B.-C., Andreasen, N. C., Flaum, M., Nopoulos, P., & Miller, D. (2000). Untreated initial psychosis: Its relation to quality of life and symptom remission in first-episode schizophrenia: American Journal of Psychiatry Vol 157(5) May 2000, 808-815.
• Ho, B.-C., Andreasen, N. C., Flaum, M., Nopoulos, P., & Miller, D. (2001). Dr. Ho and colleagues reply: American Journal of Psychiatry Vol 158(7) Jul 2001, 1162-1163.
• Ho, B.-C., Andreasen, N. C., Flaum, M., Nopoulos, P., & Miller, D. (2001). "Untreated initial psychosis: Its relation to quality of life and symptom remission in first-epidose schizophrenia": Erratum: American Journal of Psychiatry Vol 158(6) Jun 2001, 976.
• Inoue, Y., Yamada, K., Hirano, M., Shinohara, M., Tamaoki, T., Iguchi, H., et al. (2006). Impairment of theory of mind in patients in remission following first episode of schizophrenia: European Archives of Psychiatry and Clinical Neuroscience Vol 256(5) Aug 2006, 326-328.
• Inoue, Y., Yamada, K., & Kanba, S. (2006). Deficit in theory of mind is a risk for relapse of major depression: Journal of Affective Disorders Vol 95(1-3) Oct 2006, 125-127.
• Jackson, M. E., & Tessler, R. C. (1984). Perceived lack of control over life events: Antecedents and consequences in a discharged patient sample: Social Science Research Vol 13(3) Sep 1984, 287-301.
• Jensen, J. A. (1979). Hypnotic treatment of physiologically determined impairment disease: A holistic approach: Dissertation Abstracts International.
• Johansen-Berg, H., Gutman, D. A., Behrens, T. E. J., Matthews, P. M., Rushworth, M. F. S., Katz, E., et al. (2008). Anatomical connectivity of the subgenual cingulate region targeted with deep brain stimulation for treatment-resistant depression: Cerebral Cortex Vol 18(6) Jun 2008, 1374-1383.
• Kalayam, B., & Alexopoulos, G. S. (2003). A Preliminary Study of Left Frontal Region Error Negativity and Symptom Improvement in Geriatric Depression: American Journal of Psychiatry Vol 160(11) Nov 2003, 2054-2056.
• Kane, J. M., Crandall, D. T., Marcus, R. N., Eudicone, J., Pikalov, A., III, Carson, W. H., et al. (2007). Symptomatic remission in schizophrenia patients treated with aripiprazole or haloperidol for up to 52 weeks: Schizophrenia Research Vol 95(1-3) Sep 2007, 143-150.
• Karp, J. F., & Reynolds, C. F., III. (2004). Pharmacotherapy of Depression in the Elderly: Achieving and Maintaining Optimal Outcomes: Primary Psychiatry Vol 11(5) May 2004, 37-46.
• Karparova, S. P., Kersting, A., & Suslow, T. (2007). Deployment of attention in clinical depression during symptom remission: Scandinavian Journal of Psychology Vol 48(1) Feb 2007, 1-5.
• Kazantzis, N., Ronan, K. R., & Deane, F. P. (2001). Concluding causation from correlation: Comment on Burns and Spangler (2000): Journal of Consulting and Clinical Psychology Vol 69(6) Dec 2001, 1079-1083.
• Kennedy, G. J., Kelman, H. R., & Thomas, C. (1991). Persistence and remission of depressive symptoms in late life: American Journal of Psychiatry Vol 148(2) Feb 1991, 174-178.
• Khouzam, H. R., Ghafoori, B., & Nichols, E. E. A. (2005). Use of a Religious Hymn in Remission of Symptoms of Social Phobia (Social Anxiety Disorder): A Case Study: Psychological Reports Vol 96(2) Apr 2005, 411-421.
• Khouzam, H. R., & Kissmeyer, P. M. S. (1996). Physostigmine temporarily and dramatically reversing acute mania: General Hospital Psychiatry Vol 18(3) May 1996, 203-204.
• Knowles, R., Tai, S., Jones, S. H., Highfield, J., Morriss, R., & Bentall, R. P. (2007). Stability of self-esteem in bipolar disorder: Comparisons among remitted bipolar patients, remitted unipolar patients and healthy controls: Bipolar Disorders Vol 9(5) Aug 2007, 490-495.
• Kohler, C. G., & Burock, M. (2001). ECT for psychotic depression associated with a brain tumor: American Journal of Psychiatry Vol 158(12) Dec 2001, 2089.
• Kohnen, R., & Rudolph, J. (1981). Configural frequency analysis: XIV. a: Remission-controlled symptom pattern sequences in a therapy-waiting group comparison: Zeitschrift fur Klinische Psychologie und Psychotherapie Vol 29(2) 1981, 119-126.
• Kroenke, K., & Jackson, J. L. (1998). Outcome in general medical patients presenting with common symptoms: A prospective study with a 2-week and a 3-month follow-up: Family Practice Vol 15(5) Oct 1998, 398-403.
• Kwekkeboom, K., Huseby-Moore, K., & Ward, S. (1998). Imaging ability and effective use of guided imagery: Research in Nursing & Health Vol 21(3) Jun 1998, 189-198.
• Lam, R. W., Tam, E. M., Yatham, L. N., Shiah, I. S., & Zis, A. P. (2001). Seasonal depression. The dual vulnerability hypothesis revisited: Journal of Affective Disorders Vol 63(1-3) Mar 2001, 123-132.
• Lambert, M., Conus, P., Lubman, D. I., Wade, D., Yuen, H., Moritz, S., et al. (2005). The impact of substance use disorders on clinical outcome in 643 patients with first-episode psychosis: Acta Psychiatrica Scandinavica Vol 112(2) Aug 2005, 141-148.
• Lambert, M., Schimmelmann, B. G., Naber, D., Schacht, A., Karow, A., Wagner, T., et al. (2006). Prediction of remission as a combination of symptomatic and functional remission and adequate subjective well-being in 2960 patients with schizophrenia: Journal of Clinical Psychiatry Vol 67(11) Nov 2006, 1690-1697.
• Lasser, R. A., Bossie, C. A., Gharabawi, G. M., & Kane, J. M. (2005). Remission in schizophrenia: Results from a 1-year study of long-acting risperidone injection: Schizophrenia Research Vol 77(2-3) Sep 2005, 215-227.
• Lautz, R. M. (1978). Crisis intervention in brief hospitalization of schizophrenic patients: Dissertation Abstracts International.
• Lee, J. H., Reynolds, C. F., Hoch, C. C., Buysse, D. J., & et al. (1993). Electroencephalographic sleep in recently remitted, elderly depressed patients in double-blind placebo-maintenance therapy: Neuropsychopharmacology Vol 8(2) Feb 1993, 143-150.
• Leucht, S., & Lasser, R. (2006). The Concepts of Remission and Recovery in Schizophrenia: Pharmacopsychiatry Vol 39(5) Sep 2006, 161-170.
• Logsdon, M. C., Wisner, K., Hanusa, B. H., & Phillips, A. (2003). Role functioning and symptom remission in women with postpartum depression after antidepressant treatment: Archives of Psychiatric Nursing Vol 17(6) Dec 2003, 276-283.
• Lunnen, K. M., Ogles, B. M., & Pappas, L. N. (2008). A multiperspective comparison of satisfaction, symptomatic change, perceived change, and end-point functioning: Professional Psychology: Research and Practice Vol 39(2) Apr 2008, 145-152.
• Madrid, A., Rostel, G., Pennington, D., & Murphy, D. (1995). Subjective assessment of allergy relief following group hypnosis and self-hypnosis: A preliminary study: American Journal of Clinical Hypnosis 38(2) Oct 1995, 80-86.
• Malla, A. K., Norman, R. M. G., Manchanda, R., Ahmed, M. R., Scholten, D., Harricharan, R., et al. (2002). One year outcome in first episode psychosis: Influence of DUP and other predictors: Schizophrenia Research Vol 54(3) Apr 2002, 231-242.
• Mallinckrodt, B. (1996). Change in working alliance, social support, and psychological symptoms in brief therapy: Journal of Counseling Psychology Vol 43(4) Oct 1996, 448-455.
• Mancebo, M. C., Eisen, J. L., Pinto, A., Greenberg, B. D., Dyck, I. R., & Rasmussen, S. A. (2006). The Brown Longitudinal Obsessive Compulsive Study: Treatments received and patient impressions of improvement: Journal of Clinical Psychiatry Vol 67(11) Nov 2006, 1713-1720.
• McGorry, P. D., Harrigan, S. M., Amminger, P., Norman, R., & Malla, A. (2001). Untreated initial psychosis: American Journal of Psychiatry Vol 158(7) Jul 2001, 1161-1162.
• McIntyre, R. S., Fulton, K. A., Bakish, D., Jordan, J., & Kennedy, S. H. (2003). The HAM-D-sub-7: A brief depression scale to distinguish antidepressant response from symptomatic remission: Primary Psychiatry Vol 10(1) Jan 2003, 39-42.
• McKay, A. P., Tarbuck, A. F., Shapleske, J., & McKenna, P. J. (1995). Neuropsychological function in manic-depressive psychosis: Evidence for persistent deficits in patients with chronic, severe illness: British Journal of Psychiatry Vol 167(1) Jul 1995, 51-57.
• Meltzer, H. Y. (1999). Outcome in schizophrenia: Beyond symptom reduction: Journal of Clinical Psychiatry Vol 60(Suppl 3) 1999, 3-8.
• Menza, M., Marin, H., & Opper, R. S. (2003). Residual symptoms in depression: Can treatment be symptom-specific? : Journal of Clinical Psychiatry Vol 64(5) May 2003, 516-523.
• Mineur, Y. S., Picciotto, M. R., & Sanacora, G. (2007). Antidepressant-Like Effects of Ceftriaxone in Male C57BL/6J Mice: Biological Psychiatry Vol 61(2) Jan 2007, 250-252.
• Minter, R. E., Verdugo, N., & Mandel, M. R. (1980). The treatment of delusional depression with tranylcypromine: A case report: Journal of Clinical Psychiatry Vol 41(5) May 1980, 178.
• Mollick, L. R. (1977). The effect of individual and group assertion training on the behavior of hospitalized psychiatric patients: Dissertation Abstracts International.
• Montgomery, S. A. (1999). Managing the severely ill and long-term depressed: International Journal of Psychiatry in Clinical Practice Vol 3(Suppl 1) Mar 1999, S13-S17.
• Morgado, A., Raoux, N., Smith, M., Allilaire, J. F., & et al. (1989). Subjective bias in reports of poor work adjustment in depressed patients: Acta Psychiatrica Scandinavica Vol 80(6) Dec 1989, 541-547.
• Morin, M.-L. (2003). Remission of symptoms of fibromyalgia: An existential phenomenological study: Canadian Journal of Counselling Vol 37(2) Apr 2003, 84-100.
• Nader, K. (2001). Treatment methods for childhood trauma. New York, NY: Guilford Press.
• Nakao, M., Myers, P., Fricchione, G., Zuttermeister, P. C., Barsky, A. J., & Benson, H. (2001). Somatization and symptom reduction through a behavioral medicine intervention in a mind/body medicine clinic: Behavioral Medicine Vol 26(4) Win 2001, 169-176.
• Nierenberg, A. A., & Wright, E. C. (1999). Evolution of remission as the new standard in the treatment of depression: Journal of Clinical Psychiatry Vol 60(Suppl 22) 1999, 7-11.
• Nikelly, A. G., & Clados, D. (2005). Symptom remission of repatriated migrants with fibromyalgia: A pilot study: Psychiatriki Vol 16(3) Jul-Sep 2005, 209-216.
• Niskanen, P., Jaaskelainen, J., & Achte, K. (1974). Anorexia nervosa: Treatment results and prognosis: Psychiatria Fennica 1974, 257-263.
• Ono, K., Kawamura, K., Shimizu, N., Ito, C., & et al. (1990). Fetal hypothalamic brain grafts to the ventromedial hypothalamic obese rats: An immunohistochemical, electrophysiological and behavioral study: Brain Research Bulletin Vol 24(1) Jan 1990, 89-96.
• Otto, M. W. (2000). Constructing a model of change: Clinical commentary on a complex case: Cognitive and Behavioral Practice Vol 7(1) Win 2000, 123-126.
• Pallone, N. J., & Tirman, R. J. (1978). Correlates of substance abuse remission in alcoholism rehabilitation: Effective treatment or symptom abandonment? : Offender Rehabilitation Vol 3(1) Fal 1978, 7-18.
• Paolino, A. F., Konick, D. S., Friedman, I., & Graham, J. R. (1973). Changes in symptom syndromes associated with short-term psychiatric hospitalization: Journal of Community Psychology Vol 1(1) Jan 1973, 69-73.
• Passynkova, N. R., & Volf, N. V. (2001). Seasonal affective disorder: Spatial organization of EEG power and coherence in the depressive state and in light-induced and summer remission: Psychiatry Research: Neuroimaging Vol 108(3) Dec 2001, 169-185.
• Paykel, E. S. (1998). Remission and residual symptomatology in major depression: Psychopathology Vol 31(1) Jan-Feb 1998, 5-14.
• Phillips, M. (1995). Our bodies, our selves: Treating the somatic expressions of trauma with ego-state therapy: American Journal of Clinical Hypnosis 38(2) Oct 1995, 109-121.
• Pinkofsky, H. B., Hahn, A. M., Campbell, F. A., Rueda, J., Daley, D. C., & Douaihy, A. B. (2005). Reduction of Opioid-Withdrawal Symptoms With Quetiapine: Journal of Clinical Psychiatry Vol 66(10) Oct 2005, 1285-1288.
• Pollack, M. H., Endicott, J., Liebowitz, M., Russell, J., Detke, M., Spann, M., et al. (2008). Examining quality of life in patients with generalized anxiety disorder: Clinical relevance and response to duloxetine treatment: Journal of Psychiatric Research Vol 42(12) Oct 2008, 1042-1049.
• Pradhan, S. C. (2000). Gold versus silver: The issue of functional versus symptomatic recovery in depression: Journal of Clinical Psychiatry Vol 61(6) Jun 2000, 447.
• Rauch, T. M., & Lieberman, H. R. (1990). Tyrosine pretreatment reverses hypothermia-induced behavioral depression: Brain Research Bulletin Vol 24(1) Jan 1990, 147-150.
• Reus, V. I., & Rawitscher, L. (2000). Possible interaction of tramadol and antidepressants: American Journal of Psychiatry Vol 157(5) May 2000, 838.
• Reynolds, C. F., III. (2008). Preventing depression in old age: It's time: American Journal of Geriatric Psychiatry Vol 16(6) Jun 2008, 433-434.
• Robinson, D. G., Woerner, M. G., McMeniman, M., Mendelowitz, A., & Bilder, R. M. (2004). Symptomatic and Functional Recovery From a First Episode of Schizophrenia or Schizoaffective Disorder: American Journal of Psychiatry Vol 161(3) Mar 2004, 473-479.
• Rogner, J. (1994). One year after the end of an analytic Adlerian psychotherapy: II. Changes in symptomatology: Zeitschrift fur Individualpsychologie Vol 19(4) 1994, 318-326.
• Romney, D. M. (1974). Response prevention, response generalization and symptom substitution: A theoretical note: Bulletin of the British Psychological Society Vol 27(95) Apr 1974, 133-139.
• Rubin, L. S., & Barry, T. J. (1972). The effect of the cold pressor test on pupillary reactivity of schizophrenics in remission: Biological Psychiatry Vol 5(2) Oct 1972, 181-197.
• Rush, A. J., Kilner, J., Fava, M., Wisniewski, S. R., Warden, D., Nierenberg, A. A., et al. (2008). Clinically relevant findings from STAR*D: Psychiatric Annals Vol 38(3) Mar 2008, 188-193.
• Rutter, D. R. (1977). Visual interaction and speech patterning in remitted and acute schizophrenic patients: British Journal of Social & Clinical Psychology Vol 16(4) Nov 1977, 357-361.
• Salcioglu, E., Basoglu, M., & Livanou, M. (2007). Effects of live exposure on symptoms of posttraumatic stress disorder: The role of reduced behavioral avoidance in improvement: Behaviour Research and Therapy Vol 45(10) Oct 2007, 2268-2279.
• Saletu, B., & et al. (1977). Intensive antidepressive therapy by 48 hour slow-drip infusion with high doses dibenzepine: Progress in Neuro-Psychopharmacology Vol 1(1-2) 1977, 125-133.
• San, L., Ciudad, A., Alvarez, E., Bobes, J., & Gilaberte, I. (2007). Symptomatic remission and social/vocational functioning in outpatients with schizophrenia: Prevalence and associations in a cross-sectional study: European Psychiatry Vol 22(8) Nov 2007, 490-498.
• Sand, P. (1972). Neuropsychological test performance before and after symptom removal in a child with Guilles de la Tourette syndrome: Journal of Clinical Psychology Vol 28(4) Oct 1972, 596-600.
• Schajer, M. (1996). Symptom reduction in short-term phychotherapy. Dissertation Abstracts International: Section B: The Sciences and Engineering.
• Schmitz, M., Polanczyk, G., & Rohde, L. A. P. (2007). ADHD: Remission in adolescence and predictors of persistence into adulthood: Jornal Brasileiro de Psiquiatria Vol 56(Suppl1) 2007, 25-29.
• Schooler, N. R. (1996). Advances in maintenance treatment: Psychiatric Annals Vol 26(8) Aug 1996, 519-522.
• Seethalakshmi, R., Parkar, S. R., Nair, N., & Pandit, A. G. (2006). Increased thalamostriatal-mesiotemporal glucose uptake with symptom remission in schizophrenia--A case report: Journal of ECT Vol 22(1) 2006, 74-75.
• Seifritz, E. (2001). Contribution of sleep physiology to depressive pathophysiology: Neuropsychopharmacology Vol 25(Suppl5) Nov 2001, S85-S88.
• Senra, C. (1996). Evaluation and monitoring of symptom severity and change in depressed outpatients: Journal of Clinical Psychology Vol 52(3) May 1996, 317-324.
• Solodow, R. (1978). An experiment in "brief treatment" psychiatric hospitalization: Dissertation Abstracts International.
• Souetre, E., Salvati, E., Wehr, T. A., Sack, D. A., & et al. (1988). Twenty-four-hour profiles of body temperature and plasma TSH in bipolar patients during depression and during remission and in normal control subjects: American Journal of Psychiatry Vol 145(9) Sep 1988, 1133-1137.
• Stahl, S. M. (1999). Why settle for silver, when you can go for gold? Response vs. recovery as the goal of antidepressant therapy: Journal of Clinical Psychiatry Vol 60(4) Apr 1999, 213-214.
• Stahl, S. M. (2000). "Gold versus silver: The issue of functional versus symptomatic recovery in depression": Reply: Journal of Clinical Psychiatry Vol 61(6) Jun 2000, 447-448.
• Subotnik, K. L., Nuechterlein, K. H., & Green, M. F. (1999). Trait versus state aspects of the MMPI during the early course of schizophrenia: Journal of Psychiatric Research Vol 33(3) May-Jun 1999, 275-284.
• Sutcher, H. (1997). Hypnosis as adjunctive therapy for multiple sclerosis: A progress report: American Journal of Clinical Hypnosis Vol 39(4) Apr 1997, 283-290.
• Tarrier, N., Cooke, E. C., & Lader, M. H. (1978). Electrodermal and heart-rate measurements in chronic and partially remitted schizophrenic patients: Acta Psychiatrica Scandinavica Vol 57(5) May 1978, 369-376.
• Taylor, W. D., McQuoid, D. R., Steffens, D. C., & Krishnan, K. R. R. (2004). Is there a Definition of Remission in Late-Life Depression that Predicts Later Relapse? : Neuropsychopharmacology Vol 29(12) Dec 2004, 2272-2277.
• Thompson, E. A., & Reilly, D. (2002). The homeopathic approach to symptom control in the cancer patient: A prospective observational study: Palliative Medicine Vol 16(3) May 2002, 227-233.
• Tolin, D. F., & Foa, E. B. (1999). Treatment of a police officer with PTSD using prolonged exposure: Behavior Therapy Vol 30(3) Aut 1999, 527-538.
• Torgalsboen, A.-K., & Rund, B. R. (2002). Lessons learned from three studies of recovery from schizophrenia: International Review of Psychiatry Vol 14(4) Nov 2002, 312-317.
• Trivedi, M., Morris, D. W., Grannemann, B. D., & Mahadi, S. (2005). Symptom Clusters as Predictors of Late Response to Antidepressant Treatment: Journal of Clinical Psychiatry Vol 66(8) Aug 2005, 1064-1070.
• Trivedi, M. H., Rush, A. J., Fava, M., & Wisniewski, S. R. (2006). "Remission Rates for Depression in STAR*D Study": Dr. Trivedi and Colleagues Reply: American Journal of Psychiatry Vol 163(7) Jul 2006, 1293-1294.
• Trivedi, M. H., Rush, A. J., Wisniewski, S. R., Nierenberg, A. A., Warden, D., Ritz, L., et al. (2006). Evaluation of Outcomes With Citalopram for Depression Using Measurement-Based Care in STAR*D: Implications for Clinical Practice: American Journal of Psychiatry Vol 163(1) Jan 2006, 28-40.
• Uhlhaas, P. J., Phillips, W. A., & Silverstein, S. M. (2005). The course and clinical correlates of dysfunctions in visual perceptual organization in schizophrenia during the remission of psychotic symptoms: Schizophrenia Research Vol 75(2-3) Jun 2005, 183-192.
• Valentine, P. V. (2000). Traumatic Incident Reduction I: Traumatized women inmates: Particulars of practice and research: Journal of Offender Rehabilitation Vol 31(3-4) 2000, 1-15.
• Vansteenwegen, D., Vervliet, B., Hermans, D., Thewissen, R., & Eelen, P. (2007). Verbal, behavioural and physiological assessment of the generalization of exposure-based fear reduction in a spider-anxious population: Behaviour Research and Therapy Vol 45(2) Feb 2007, 291-300.
• Venner, K. L., & Feldstein, S. W. (2006). Natural History of Alcohol Dependence and Remission Events for a Native American Sample: Journal of Studies on Alcohol Vol 67(5) Sep 2006, 675-684.
• Vilela, W. A. (1989). Kurt Schneider's first order symptoms of schizophrenia: Relation with the developmental course and personality: Jornal Brasileiro de Psiquiatria Vol 38(4) Jul-Aug 1989, 165-173.
• Villeneuve, E., & Lemelin, S. (2005). Open-Label Study of Atypical Neuroleptic Quetiapine for Treatment of Borderline Personality Disorder: Impulsivity as Main Target: Journal of Clinical Psychiatry Vol 66(10) Oct 2005, 1298-1303.
• Viola, J., Ditzler, T., Batzer, W., Harazin, J., Adams, D., Lettich, L., et al. (1997). Pharmacological management of post-traumatic stress disorder: Clinical summary of a five-year retrospective study, 1990-1995: Military Medicine Vol 162(9) Sep 1997, 616-619.
• Wang, X., Savage, R., Borisov, A., Rosenberg, J., Woolwine, B., Tucker, M., et al. (2006). Efficacy of risperidone versus olanzapine in patients with schizophrenia previously on chronic conventional antipsychotic therapy: A switch study: Journal of Psychiatric Research Vol 40(7) Oct 2006, 669-676.
• Weise, C. C., O'Reilly, P., & Hesbacher, P. (1972). Perphenazine-amitriptyline in neurotic underachieving students: A controlled study: Diseases of the Nervous System Vol 33(5) May 1972, 318-325.
• Wen-Chi Ho, A., & Birmingham, C. L. (2001). Anorexia nervosa remission during an episode of encephalitis: International Journal of Eating Disorders Vol 29(1) Jan 2001, 97-99.
• Wilkinson, D., Murray, J., & Galantamine Research, G. (2001). Galantamine: A randomized, double-blind, dose comparison in patients with Alzheimer's disease: International Journal of Geriatric Psychiatry Vol 16(9) Sep 2001, 852-857.
• Wong, S. (2006). Treatment of Depression Should be Individualized to Improve Response: CNS Spectrums Vol 11(12) Dec 2006, 909-910.
• Wunderink, L., Nienhuis, F. J., Sytema, S., & Wiersma, D. (2007). Predictive validity of proposed remission criteria in first-episode schizophrenic patients responding to antipsychotics: Schizophrenia Bulletin Vol 33(3) May 2007, 792-796.
• Young, S., & Gudjonsson, G. H. (2008). Growing out of ADHD: The relationship between functioning and symptoms: Journal of Attention Disorders Vol 12(2) Sep 2008, 162-169.
• Zanarini, M. C., Frankenburg, F. R., Hennen, J., Reich, B., & Silk, K. R. (2005). The McLean Study of Adult Development (MSAD): Overview and implications of the first six years of prospective follow-up: Journal of Personality Disorders Vol 19(5) Oct 2005, 505-523.
• Zimmerman, M., Posternak, M. A., & Chelminski, I. (2004). Defining remission on the Montgomery-Asberg depression rating scale: Journal of Clinical Psychiatry Vol 65(2) Feb 2004, 163-168.

Additional material

Papers

• Google Scholar